2012
DOI: 10.1038/ncomms1889
|View full text |Cite
|
Sign up to set email alerts
|

Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase

Abstract: Poly(ADP-ribosyl)ation is a reversible post-translational protein modification involved in the regulation of a number of cellular processes including DnA repair, chromatin structure, mitosis, transcription, checkpoint activation, apoptosis and asexual development. The reversion of poly(ADP-ribosyl)ation is catalysed by poly(ADP-ribose) (PAR) glycohydrolase (PARG), which specifically targets the unique PAR (1′′-2′) ribose-ribose bonds. Here we report the structure and mechanism of the first canonical PARG from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
98
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 78 publications
(103 citation statements)
references
References 30 publications
3
98
2
Order By: Relevance
“…Furthermore, such studies also provide the means to develop inhibitors against specific PARPs as important tools to study these processes, but these inhibitors are already making their way into the clinic to treat specific types of cancers as well as cardiovascular and neurodegenerative diseases (Papeo et al, 2013). Inhibiting PAR degrading enzymes has also been proposed as an alternative approach in the clinic (Dunstan et al, 2012;Min and Wang, 2009). The specificity of such inhibitors is highly important; therefore, furthering our insight into the structure and function of the remaining PARPs and other proteins involved in ADP-ribosylation signaling would benefit the drug design efforts.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Furthermore, such studies also provide the means to develop inhibitors against specific PARPs as important tools to study these processes, but these inhibitors are already making their way into the clinic to treat specific types of cancers as well as cardiovascular and neurodegenerative diseases (Papeo et al, 2013). Inhibiting PAR degrading enzymes has also been proposed as an alternative approach in the clinic (Dunstan et al, 2012;Min and Wang, 2009). The specificity of such inhibitors is highly important; therefore, furthering our insight into the structure and function of the remaining PARPs and other proteins involved in ADP-ribosylation signaling would benefit the drug design efforts.…”
Section: Discussionmentioning
confidence: 97%
“…Human as well as other vertebrate PARGs are composed of three domains: two of these domains, namely macrodomain and the PARG accessory domain, make up the minimal PARG catalytic region, while the third domain, which shows significantly less sequence conservation, is the putative PARG regulatory region (Figure 4) (Dunstan et al, 2012;Patel et al, 2005;Slade et al, 2011;Tucker et al, 2012). The latter regulatory domain is absent in PARGs of the majority of eukaryotes, and it is not important for PAR hydrolysis in vitro (Botta and Jacobson, 2010;Slade et al, 2011).…”
Section: Pargmentioning
confidence: 97%
See 1 more Smart Citation
“…Dynamic docking of substrate into BfrA active site was performed as previously reported for other proteins-ligand complexes models. [52][53][54] Ligands were placed in BfrA model active site using fructose orientation in 3PIJ X-ray structure. The complex was then equilibrated by keeping protein backbone restrained on the model conformation.…”
Section: Molecular Modelingmentioning
confidence: 99%
“…Since degradation occurs when the polymer is available, PAR-binding proteins can potentially counteract PARG. PARG is actually unable to cleave the proximal ADP-ribose monomer, which appears to be due to steric hindrance [163]. ADP-ribose units are removed from mono(ADP-ribosyl)ated proteins by specific enzymes [164].…”
Section: Poly(adp-ribose) and Poly(adp-ribosyl)ationmentioning
confidence: 99%